David Mountcastle Sells 5,630 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVAGet Free Report) CFO David Mountcastle sold 5,630 shares of the company’s stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total value of $125,999.40. Following the completion of the transaction, the chief financial officer now directly owns 179,676 shares of the company’s stock, valued at approximately $4,021,148.88. This trade represents a 3.04 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Privia Health Group Trading Down 1.2 %

PRVA opened at $21.97 on Friday. Privia Health Group, Inc. has a 1-year low of $15.92 and a 1-year high of $26.04. The stock has a market capitalization of $2.65 billion, a PE ratio of 219.72, a PEG ratio of 3.47 and a beta of 0.85. The firm has a 50-day moving average price of $23.78 and a two-hundred day moving average price of $21.29.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on PRVA shares. Needham & Company LLC restated a “buy” rating and issued a $30.00 target price on shares of Privia Health Group in a research note on Friday, March 21st. Piper Sandler raised their price objective on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a report on Friday, February 28th. Canaccord Genuity Group upped their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, February 28th. JMP Securities set a $29.00 price target on shares of Privia Health Group in a research note on Friday, February 28th. Finally, Stephens reissued an “overweight” rating and issued a $26.00 target price on shares of Privia Health Group in a report on Thursday, January 2nd. One research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $26.67.

View Our Latest Research Report on Privia Health Group

Institutional Trading of Privia Health Group

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Quadrant Capital Group LLC boosted its position in Privia Health Group by 11.8% in the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock valued at $95,000 after buying an additional 511 shares during the last quarter. Park Avenue Securities LLC boosted its holdings in Privia Health Group by 3.8% in the fourth quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock valued at $287,000 after acquiring an additional 532 shares during the last quarter. PNC Financial Services Group Inc. increased its position in Privia Health Group by 8.0% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company’s stock worth $140,000 after purchasing an additional 533 shares during the period. First Horizon Advisors Inc. raised its holdings in Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after purchasing an additional 632 shares during the last quarter. Finally, Summit Investment Advisors Inc. lifted its position in Privia Health Group by 6.8% during the 4th quarter. Summit Investment Advisors Inc. now owns 10,673 shares of the company’s stock valued at $209,000 after purchasing an additional 678 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Company Profile

(Get Free Report)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Read More

Insider Buying and Selling by Quarter for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.